NASDAQ: SPRY
Ars Pharmaceuticals Inc Stock Ownership - Who owns Ars Pharmaceuticals?

Insider buying vs selling

Have Ars Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Laura ShawverDirector2025-02-0340,936$4.85
$198.54kBuy
Laura ShawverDirector2025-02-039,064$3.15
$28.55kBuy
Laura ShawverDirector2025-02-0350,000$12.31
$615.55kSell
Laura ShawverDirector2025-01-0650,000$11.10
$555.05kSell
Laura ShawverDirector2025-01-0650,000$3.15
$157.50kBuy
Richard E. LowenthalPRESIDENT AND CEO2024-12-1750,000$11.67
$583.55kSell
Richard E. LowenthalPRESIDENT AND CEO2024-12-1750,000$11.67
$583.55kSell
Sarina TanimotoCHIEF MEDICAL OFFICER2024-12-1750,000$11.67
$583.55kSell
Sarina TanimotoCHIEF MEDICAL OFFICER2024-12-1750,000$11.67
$583.55kSell
Justin ChakmaChief Business Officer2024-12-1327,272$1.44
$39.27kBuy

1 of 24

SPRY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SPRY insiders and whales buy or sell their stock.

SPRY Shareholders

What type of owners hold Ars Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC17.52%17,029,398$204.69MInsider
Peter A. Thompson17.52%17,029,398$204.69MInsider
Richard E. Lowenthal14.71%14,291,828$171.79MInsider
Sarina Tanimoto13.02%12,649,635$152.05MInsider
James E. Flynn10.82%10,514,657$126.39MInsider
Pratik Shah4.96%4,824,554$57.99MInsider
Blackrock Inc4.71%4,574,491$54.99MInstitution
Jonathan D. Root4.57%4,445,960$53.44MInsider
Sr One Capital Management LP4.13%4,012,903$48.24MInstitution
Alliancebernstein LP3.99%3,880,734$46.65MInstitution

1 of 3

SPRY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SPRY27.57%72.43%Net SellingNet Selling
SYRE61.33%38.67%Net Selling
OCUL58.86%23.08%Net BuyingNet Selling
XNCR66.37%33.63%Net BuyingNet Buying
RCUS56.46%43.54%Net SellingNet Selling

Ars Pharmaceuticals Stock Ownership FAQ

Who owns Ars Pharmaceuticals?

Ars Pharmaceuticals (NASDAQ: SPRY) is owned by 35.42% institutional shareholders, 93.04% Ars Pharmaceuticals insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Ars Pharmaceuticals shareholder, owning 17.03M shares representing 17.52% of the company. Orbimed Advisors LLC's Ars Pharmaceuticals shares are currently valued at $204.69M.

If you're new to stock investing, here's how to buy Ars Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.